Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-alpha production. [GOC:mah, PMID:15546383]
Negative regulation of interferon-alpha (IFN-α) production is a complex process that involves a variety of cellular mechanisms aimed at controlling the levels of this key antiviral cytokine. IFN-α is a potent activator of the innate immune response, playing a crucial role in the defense against viral infections. However, excessive or uncontrolled IFN-α production can lead to detrimental effects, including autoimmune disorders and inflammation. Therefore, tightly regulated mechanisms are essential to ensure proper IFN-α levels.
One of the primary mechanisms of negative regulation involves the suppression of IFN-α gene transcription. This can be achieved through several pathways, including:
1. **Inhibition of signal transduction pathways:** Viral infection triggers signaling pathways that ultimately lead to IFN-α gene expression. These pathways involve activation of transcription factors like IRF3 and IRF7, which bind to the IFN-α promoter and initiate transcription. Negative regulation can occur by inhibiting the activation of these transcription factors. For instance, viral proteins can directly interact with and inhibit kinases like TBK1 and IKKε, which are essential for IRF3 and IRF7 phosphorylation and activation.
2. **Induction of negative regulators:** Several proteins act as negative regulators of IFN-α production. For example, the protein SOCS1 (suppressor of cytokine signaling 1) can inhibit the signaling pathways leading to IFN-α production by blocking the JAK-STAT pathway. Other proteins like A20 and USP18 can act as deubiquitinases, removing ubiquitin tags from key signaling molecules, thereby attenuating the signaling cascade.
3. **Direct binding to the IFN-α promoter:** Some proteins can directly bind to the IFN-α promoter and inhibit its accessibility to transcription factors, thereby preventing IFN-α gene expression. For example, the protein c-Fos can bind to the IFN-α promoter and suppress its activity.
In addition to transcriptional regulation, post-transcriptional control mechanisms also play a role in negative regulation of IFN-α production. These include:
1. **mRNA degradation:** The stability of IFN-α mRNA can be controlled through mechanisms that target its degradation. MicroRNAs (miRNAs) can bind to the 3' untranslated region (UTR) of IFN-α mRNA, promoting its degradation.
2. **Protein degradation:** IFN-α protein itself can be targeted for degradation by the ubiquitin-proteasome system. This process can be triggered by various mechanisms, including viral proteins that interact with IFN-α and target it for degradation.
Overall, negative regulation of IFN-α production is a multi-faceted process that involves a complex interplay of cellular pathways, protein interactions, and gene expression regulation. This elaborate system ensures that IFN-α levels are tightly controlled, preventing excessive activation of the immune system while maintaining the antiviral response necessary for effective defense against viral infections.'
"
Protein | Definition | Taxonomy |
---|---|---|
Hepatitis A virus cellular receptor 2 | A hepatitis A virus cellular receptor 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8TDQ0] | Homo sapiens (human) |
Receptor-type tyrosine-protein phosphatase S | A receptor-type tyrosine-protein phosphatase S that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13332] | Homo sapiens (human) |
Interleukin-10 | An interleukin-10 that is encoded in the genome of human. [PRO:JAN, UniProtKB:P22301] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-chloro-1h-benzimidazole-2-thiol | 5-chloro-1H-benzimidazole-2-thiol: trypanocidal | ||
baicalein | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger | |
morin | morin : A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. morin: a light yellowish pigment found in the wood of old fustic (Chlorophora tinctoria) | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent |
scutellarein | scutellarein : Flavone substituted with hydroxy groups at C-4', -5, -6 and -7. scutellarein: aglycone of scutellarin from Scutellaria baicalensis; carthamidin is 2S isomer of scutellarein; do not confuse with isoscutellarein and/or isocarthamidin which are respective regioisomers, or with the scutelarin protein | tetrahydroxyflavone | metabolite |
tricetin | tricetin : Flavone hydroxylated at positions 3', 4', 5, 5' and 7. | pentahydroxyflavone | antineoplastic agent; metabolite |
hg-9-91-01 | HG-9-91-01 : A member of the class of phenylureas that is a potent inhibitor of salt-inducible kinase 2, a potential target protein for therapy in ovarian cancer. HG-9-91-01: inhibits salt-inducible kinases; structure in first source | aminopyrimidine; dimethoxybenzene; N-alkylpiperazine; N-arylpiperazine; phenylureas; secondary amino compound | antineoplastic agent; salt-inducible kinase 2 inhibitor |